Follow
Jakub Hlávka
Jakub Hlávka
Other namesJakub P. Hlávka
Masaryk University, Brno, Czech Republic; USC Schaeffer Center, USC Keck School of Medicine
Verified email at usc.edu - Homepage
Title
Cited by
Cited by
Year
Biosimilar cost savings in the United States: initial experience and future potential
AW Mulcahy, JP Hlávka, SR Case
RAND Health Quarterly 7 (4), 2018
2672018
Artificial Intelligence in Healthcare
A Bohr, K Memarzadeh, (editors)
Academic Press, 2020
2582020
Improving Representation in Clinical Trials and Research: Building Research Equity for Women and Underrepresented Groups
National Academies of Sciences, Engineering, and Medicine
https://nap.nationalacademies.org/read/26479/chapter/1, 2022
1432022
Assessing the preparedness of the US health care system infrastructure for an Alzheimer’s treatment
JL Liu, JP Hlávka, R Hillestad, S Mattke
The RAND Corporation, Santa Monica, CA, 2017
1012017
Assessing the Preparedness of the Health Care System Infrastructure in Six European Countries for an Alzheimer's Treatment
JP Hlavka, S Mattke, JL Liu
RAND Health Quarterly 8 (3), 2019
1002019
Toward a Sustainable Blood Supply in the United States
AW Mulcahy, K Kapinos, B Briscombe, L Uscher-Pines, R Chaturvedi, ...
Santa Monica (CA): RAND Corporation, 2016
642016
Blood‐based biomarkers for Alzheimer's pathology and the diagnostic process for a disease‐modifying treatment: Projecting the impact on the cost and wait times
MH Soeren Mattke, Sang Kyu Cho, Tobias Bittner, Jakub Hlávka
Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring, 2020
562020
Macroeconomic consequences of the COVID-19 pandemic
T Walmsley, A Rose, R John, D Wei, JP Hlávka, J Machado, K Byrd
Economic modelling 120, 106147, 2023
522023
Security, privacy, and information-sharing aspects of healthcare artificial intelligence
JP Hlávka
Artificial Intelligence in Healthcare, 235-270, 2020
322020
Assessing the preparedness of the Canadian health care system infrastructure for an Alzheimer's treatment
J Liu, J Hlávka, D Coulter, SM Baxi, S Mattke, CA Gidengil
RAND, 2019
272019
Security Sector Reform in Ukraine
O Oliker, LE Davis, K Crane, A Radin, CW Gventer, S Sondergaard, ...
RAND Corporation, 2016
262016
The potential emergence of disease-modifying treatments for Alzheimer disease: the role of primary care in managing the patient journey
J Lam, J Hlávka, S Mattke
The Journal of the American Board of Family Medicine 32 (6), 931-940, 2019
252019
US Presence and the Incidence of Conflict
A O’Mahony, BF Miranda Priebe, J Kavanagh, M Lane, T Johnston, ...
RAND Corporation, 2018
222018
Challenges to the Sustainability of the US Public Cord Blood System
KA Kapinos, B Briscombe, T Gracner, A Strong, C Whaley, E Hoch, ...
RAND Corporation, 2017
212017
Targeted interoperability: a new imperative for multinational operations
CG Pernin, J Osburg, M Shurkin, JP Hlavka, M Lerario, J Gordon IV, ...
RAND Corporation, 2019
202019
Lessons from Others for Future US Army Operations in and Through the Information Environment
C Paul, CP Clarke, M Schwille, JP Hlávka, MA Brown, SS Davenport, ...
RAND Corporation, 2018
152018
3D printing: Downstream production transforming the supply chain
S Veronneau, G Torrington, JP Hlávka
RAND Corporation Santa Monica United States, 2017
142017
Assessing the preparedness of the Japanese health care system infrastructure for an Alzheimer’s treatment
S Mattke, J Hlávka, J Yoong, M Wang, R Goto
132019
The economics of alternative payment models for pharmaceuticals
JP Hlávka, JC Yu, DP Goldman, DN Lakdawalla
The European Journal of Health Economics 22, 559-569, 2021
122021
Factors associated with biosimilar exclusions and step therapy restrictions among US commercial health plans
T Yu, S Jin, C Li, JD Chambers, JP Hlávka
BioDrugs 37 (4), 531-540, 2023
102023
The system can't perform the operation now. Try again later.
Articles 1–20